● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

AKUMS

BSE
Akums Drugs and Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE09XN01023· Scrip: 544222
ENहिन्दीગુજરાતીमराठी
592.35
43.75 (+0.00%)
2026-06-10
BSE
592.35
43.75
+0.00%
41245850455159706-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open550.50
High595.25
Low545.00
Prev Close548.60
Volume5.47L
Value₹31.4Cr
L: 545.00H: 595.25
Info
Face Value₹2
Listed2024-08-06
ISININE09XN01023
SeriesB
BSE Scrip544222

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-2.19%
PAT-0.51%
EPS-2.52%

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr258 Cr517 Cr775 Cr1033 Cr24-0624-0924-124.24.44.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-311010 Cr939 Cr165 Cr91 Cr66 Cr4.26
2024-09-301033 Cr959 Cr163 Cr92 Cr67 Cr4.37
2024-06-301019 Cr938 Cr161 Cr87 Cr61 Cr4.21

Shareholding Pattern

CURRENT2026-03-31
75.3%PROMOTER
Promoter75.3%
FII1.4%
DII14.3%
Public22.0%
PROMOTER HOLDING TREND
75.3%24-0875.3%24-0975.3%24-1275.3%25-0375.3%25-0975.3%25-1275.3%26-03

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10546.00595.90545.00592.1013.89L
2026-06-03531.90545.00529.00540.451.49L
2026-05-27535.05548.50535.00535.252.18L
2026-05-26521.60551.60521.60532.203.02L
2026-05-25530.00531.85514.90521.001.19L
2026-05-22523.50525.45516.60520.052.22L
2026-05-21516.00527.40509.15521.352.21L
2026-05-20516.00523.65510.35514.953.22L
2026-05-19519.75530.90517.95519.803.01L
2026-05-18512.45533.10505.55519.756.10L
2026-05-15531.70532.30500.05516.953.88L
2026-05-14545.90557.00512.65527.9010.16L
2026-05-13528.40550.00528.40540.351.50L
2026-05-12543.05548.60523.50528.404.12L
2026-05-11557.95567.00535.10538.752.53L
2026-05-08546.80561.00546.80557.101.62L
2026-05-07555.90560.00545.00548.001.08L
2026-05-06553.60560.40550.15552.151.20L
2026-05-05560.00562.10550.00552.8089,269
2026-05-04550.00563.85544.60559.153.50L
2026-04-30542.10549.95536.65547.302.52L
2026-04-29531.00550.00527.85543.701.57L
2026-04-28530.00539.80529.95533.2084,212
2026-04-27525.90532.70513.90531.301.58L
2026-04-24544.20546.90512.10514.302.01L
2026-04-23526.00547.45526.00539.501.73L
2026-04-22528.90538.50526.05528.751.07L
2026-04-21533.30539.50532.05534.3077,889
2026-04-20545.75546.90531.25533.301.04L
2026-04-17550.50557.00544.15545.751.45L

Frequently Asked Questions

About

Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization (CDMO) serving domestic and multinational companies, also operating as a pharmaceutical manufacturer with DSIR-approved R&D and NABL-accredited labs. Key products include formulations and APIs, with a notable milestone being its establishment in 1994.

BOARD OF DIRECTORS
Nand Lal Kalra
Independent Director
DEPARTED
Anil Kumar Arvindlal Amin
Additional Director